Patents Assigned to BNIW Ventures LLC.
  • Patent number: 11071718
    Abstract: Provided are methods of treating a neurological or psychiatric disorder in a subject in need thereof, comprising: administering to the subject a therapeutically effective amount of ketamine or a pharmaceutically acceptable salt thereof in combination with an amount of one or more compounds effective to increase the level of nicotinamide adenine dinucleotide (NAD+) in the subject.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: July 27, 2021
    Assignee: BNIW Ventures LLC.
    Inventors: Guriqbal S. Nandra, Irvin M. Wiesman
  • Patent number: 10555917
    Abstract: Provided are methods of treating a neurological or psychiatric disorder in a subject in need thereof, comprising: administering to the subject a therapeutically effective amount of ketamine or a pharmaceutically acceptable salt thereof in combination with an amount of one or more compounds effective to increase the level of nicotinamide adenine dinucleotide (NAD+) in the subject.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: February 11, 2020
    Assignee: BNIW Ventures LLC.
    Inventors: Guriqbal S. Nandra, Irvin M. Wiesman